Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.76B |
| 2 |
Ferguson
FERG
|
+$1.35B |
| 3 |
Walt Disney
DIS
|
+$1.19B |
| 4 |
Huntington Bancshares
HBAN
|
+$1.12B |
| 5 |
DoorDash
DASH
|
+$1.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$2.38B |
| 2 |
American Express
AXP
|
+$1.79B |
| 3 |
Apple
AAPL
|
+$1.73B |
| 4 |
Microsoft
MSFT
|
+$1.36B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.28B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.27% |
| 2 | Healthcare | 17.16% |
| 3 | Financials | 15.27% |
| 4 | Consumer Discretionary | 9.7% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Dr. Reddy's Laboratories
RDY
$10.1B
| $1.69M | ﹤0.01% |
120,244
| – | – |
|
1552
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
| $1.68M | ﹤0.01% |
109,137
-116,772
| -52% | -$9.41M |
|
1553
Las Vegas Sands
LVS
$29.7B
| $1.67M | ﹤0.01% |
25,677
+13,060
| +104% | +$800K |
|
1554
Fulcrum Therapeutics
FULC
$288M
| $1.66M | ﹤0.01% |
146,427
-32,931
| -18% | -$335K |
|
1555
ArriVent BioPharma
AVBP
$1.43B
| $1.66M | ﹤0.01% |
82,278
+532
| +0.7% | +$11.1K |
|
1556
Cullinan Oncology
CGEM
$1.08B
| $1.65M | ﹤0.01% |
159,751
-8,380
| -5% | -$75.6K |
|
|
1557
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
| $1.65M | ﹤0.01% |
20,475
-639,675
| -97% | -$51.6M |
|
|
ALMS
1558
Alumis Inc
ALMS
$3.46B
| $1.65M | ﹤0.01% |
169,093
+3,590
| +2% | +$25.1K |
|
|
CBIO
1559
Crescent Biopharma
CBIO
$586M
| $1.63M | ﹤0.01% |
143,412
+125,714
| +710% | +$1.6M |
|
1560
Evergy
EVRG
$19.1B
| $1.62M | ﹤0.01% |
22,351
+6,026
| +37% | +$457K |
|
1561
Ligand Pharmaceuticals
LGND
$6.06B
| $1.59M | ﹤0.01% |
8,426
+110
| +1% | +$21.1K |
|
1562
Skyworks Solutions
SWKS
$10.1B
| $1.59M | ﹤0.01% |
25,102
+7,573
| +43% | +$529K |
|
|
JBIO
1563
Jade Biosciences
JBIO
$1.32B
| $1.58M | ﹤0.01% |
102,620
-4,933
| -5% | -$57.9K |
|
|
SION
1564
Sionna Therapeutics
SION
$2.14B
| $1.58M | ﹤0.01% |
38,347
-3,887
| -9% | -$147K |
|
1565
Vanda Pharmaceuticals
VNDA
$306M
| $1.58M | ﹤0.01% |
178,851
-10,196
| -5% | -$56.1K |
|
1566
Oric Pharmaceuticals
ORIC
$1.34B
| $1.57M | ﹤0.01% |
191,823
+41,229
| +27% | +$475K |
|
1567
Concentrix
CNXC
$1.59B
| $1.55M | ﹤0.01% |
37,375
-1,459
| -4% | -$59.2K |
|
1568
SLM Corp
SLM
$5.16B
| $1.54M | ﹤0.01% |
56,742
-3,208
| -5% | -$88K |
|
1569
Zevra Therapeutics
ZVRA
$622M
| $1.53M | ﹤0.01% |
170,309
-16,957
| -9% | -$160K |
|
1570
HCI Group
HCI
$2.28B
| $1.51M | ﹤0.01% |
7,884
-345,051
| -98% | -$65M |
|
|
SCHW
1571
Charles Schwab
SCHW
$188B
| $1.5M | ﹤0.01% |
14,990
-8,051,901
| -100% | -$764M |
|
1572
TransDigm Group
TDG
$70.2B
| $1.47M | ﹤0.01% |
1,105
-1,804
| -62% | -$2.36M |
|
1573
Strategy Inc
MSTR
$35.9B
| $1.46M | ﹤0.01% |
9,621
-1,000
| -9% | -$230K |
|
1574
Globus Medical
GMED
$10.9B
| $1.46M | ﹤0.01% |
16,676
-848,880
| -98% | -$64.4M |
|
1575
FMC
FMC
$1.35B
| $1.44M | ﹤0.01% |
103,948
-4,904,339
| -98% | -$93.5M |
|
Similar funds
Wellington Management Group's Q4 2025 Portfolio in Review
As of Q4 2025, Wellington Management Group held 2,121 positions worth $571B, down 0.12% from $571B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Wellington Management Group withdrew a net $21.4B in Q4 2025, closing 209 positions and reducing 884 holdings. Its most notable exit was Interpublic Group of Companies, an estimated $389M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Wellington Management Group opened a new position in The Magnum Ice Cream Company N.V. worth $405M.
- Wellington Management Group's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 25,391,614 shares worth $405M.
- Wellington Management Group added most to Amazon in Q4 2025, an estimated $1.76B increase.
- Wellington Management Group's biggest Q4 2025 reduction was Alphabet (Google) Class A, cutting an estimated $2.38B.
- Wellington Management Group fully exited Interpublic Group of Companies in Q4 2025, selling an estimated $389M.
- Wellington Management Group's ten largest holdings make up 28% of its $571B portfolio in Q4 2025.
- Wellington Management Group opened 152 new positions and closed 209 in Q4 2025.
- Wellington Management Group's portfolio value fell 0.12% quarter-over-quarter to $571B.
Based on Wellington Management Group's 13F filing for Q4 2025, filed 17 Feb 2026.